Back to company

ABBLO PHARMA ApS: Financial statements 2020

CVR: 34080534

ABBLO PHARMA ApS (CVR 34080534) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 375,630 and a net result of DKK 213,834 compared with DKK 100,475 the year before. That is an increase of 22.6% compared with the year before. Equity amounted to DKK -914,429. The company had 1 employee in the financial year.

Gross Profit
375,630 kr.
Profit/Loss
213,834 kr.
Equity
-914,429 kr.
Total Assets
764,108 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-376 t.214 t.-914 t.1
2019-306 t.100 t.-1.1 mio.1
2018-146 t.12 t.-1.2 mio.1
2017-120 t.-84 t.-1.2 mio.1
2016--217 t.-380 t.-1.2 mio.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is ABBLO PHARMA ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

ABBLO PHARMA ApS: The 2019 annual report is outApr 8, 2020

ABBLO PHARMA ApS has published its annual report for 2019. Gross profit came to DKK 306,373, and the net result was DKK 100,475.

About ABBLO PHARMA ApS

ABBLO PHARMA ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2011. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Nic Borch-Christensen and Mie Hjerrild Petersen. The company is owned by ABBLO S.à.r.l. The company has 0 employees. In 2025, the company reported a gross profit of DKK 471,866 and a net result of DKK -152,259 compared with DKK 135,215 the year before. Equity amounted to DKK -238,088.